Notice of application.
Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before January 6, 2020.
Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.
Start Supplemental Information
In accordance with 21 CFR 1301.33(a), this is notice that on September 9, 2019, Organix, Inc., 240 Salem Street, Woburn, Massachusetts 01801-2029 applied to be registered as a bulk manufacturer of the following basic classes of controlled substances:
|Controlled substance||Drug code||Schedule|
|Gamma Hydroxybutyric Acid||2010||I|
|Lysergic acid diethylamide||7315||I|
The company plans to synthesize the listed controlled substances for distribution to its customers. In reference to drug codes 7360 (marihuana) and 7370 (THC), the company plans to bulk manufacture these drugs as synthetics. No other activities for these drug codes are authorized for this registration.
End Supplemental Information
Dated: October 18, 2019.
William T. McDermott,
[FR Doc. 2019-24107 Filed 11-4-19; 8:45 am]
BILLING CODE 4410-09-P